Our story

Lead Pharma is a spinoff from the prestigious Hubrecht Institute and the University Medical Center Utrecht. We develop innovative small-molecule therapies for patients with autoimmune disease or cancer.

Lead Pharma is headquartered at Pivot Park, the biopharmaceutical life sciences campus in Oss, the Netherlands. We have fully equipped labs for all stages of drug discovery, including medicinal chemistry, cellular pharmacology, and molecular pharmacology, as well as an in silico lab for our computational chemistry, bioinformatics and data mining activities. We work with a select network of specialized contract research organizations to whom we outsource our in vivo pharmacology and toxicology studies.

Lead Pharma has a qualified team of 29 employees, including 10 with a PhD degree, who have long-term experience working in large pharmaceutical companies, biotech companies and academia.

Our people

The quality of our people is at the heart of our innovative success!

Our team members have a wealth of experience when it comes to drug discovery, drug design, translational medicine, and development. The success of our team does not rely only on high quality standards and effective teamwork, but also on agility, creativity, inspiration and passion.

Management Board

Frans van den Berg

Frans van den Berg, MSc, MBA
Chief Executive Officer

Frans van den Berg, MSc, MBA
Chief Executive Officer

Arthur Oubrie

Arthur Oubrie, PhD
Chief Scientific Officer

Arthur Oubrie, PhD
Chief Scientific Officer

Supervisory Board

Investors

BOM Brabant Ventures
Oost NL
Biox Biosciences
Waterman Ventures